Own report: Despite the emphasis on vaccination to prevent coronavirus, there have been many complaints about the price of the vaccine from the very beginning. At present there are 2 vaccines in the country. One is Covishield, a leading institute of India, the other is Covacin produced by India Biotech. But the problem is that these two vaccines are being sold in 20 different countries Which raises the question

Aman Chopra, editor of Zee News, discusses the different prices of this same vaccine in India. In addition, the general public has been told how much this system can affect.

Both Serum and Bharat Biotech are selling their vaccines to the central government at Rs 150 per dose. The government is giving this vaccine free of cost to those above 45 years of age in the country. Serum, meanwhile, is selling its Covishield vaccine to state governments at Rs 300 per dose, while India Biotech is selling it to state governments at Rs 400 per dose.

Read more, Russia’s Sputnik V vaccine has been approved in India

In private hospitals Covishield is being sold at Rs 600 per dose, Covacin at Rs 1,200. The state government is also providing free vaccines to 18- to 44-year-olds. But if you have to take it privately, the cost will be Rs. 1800 per vaccine

This is where the speculation begins. Private hospitals are bringing life-giving products like vaccines into ‘profitable’ products It is clear from the price manipulation that they are making huge profits from the Corona vaccine. The survey found that 91% of people in the country agreed to go to a private hospital and get a free vaccine at a government center without having to pay so much.

In such a situation, many people have spoken about starting one country, one vaccination system. Apart from the Center, the state government can also raise the price of vaccines. But time will tell whether this price difference will be met at all.

(Zee 24 Ghanta App : Country, World, State, Kolkata, Entertainment, Sports, Lifestyle Health, Technology Read Latest News Zee 24 Ghanta App)